• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单纯药物涂层球囊血管成形术与定向斑块旋切术联合药物涂层球囊血管成形术治疗下肢间歇性跛行外周动脉疾病患者的比较

Comparison of Drug-Coated Balloon Angioplasty Alone and Directional Atherectomy Combined with Drug-Coated Balloon Angioplasty in Patients with Lower Extremity Peripheral Arterial Disease with Claudication.

作者信息

Kavala Ali Aycan, Kuserli Yusuf, Turkyilmaz Gulsum, Yesiltas Mehmet Ali, Turkyilmaz Saygin

机构信息

Department of Cardiovascular Surgery, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey.

Department of Cardiovascular Surgery, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey.

出版信息

Ann Vasc Surg. 2023 Mar;90:162-171. doi: 10.1016/j.avsg.2022.10.007. Epub 2022 Oct 28.

DOI:10.1016/j.avsg.2022.10.007
PMID:36404474
Abstract

BACKGROUND

The objective of the study was to compare drug-coated balloon (DCB) angioplasty alone and directional atherectomy (DA) combined with DCB angioplasty in patients with lower extremity peripheral arterial disease (LE-PAD).

METHODS

Subjects treated with DCB angioplasty alone (group A) and DA combined with DCB angioplasty (group B) were enrolled in the study. A retrospective chart review was performed between the 4 years. Subjects with severe and occluded LE-PAD were included. Demographic data, atherosclerotic vessel properties, and procedural data were recorded. For both groups, success rates (technical, procedural, and clinical) were presented.

RESULTS

In total, 226 patients were evaluated. For baseline characteristics, only tobacco use and hyperlipidemia were higher in group B (P = 0.001 and P = 0.010, respectively). For the ankle-brachial index, no significant difference existed at the first, third, sixth, 12th or 24th month follow-ups. No significant difference existed for the Rutherford class at the first, third, sixth, or 12th months according to the groups. A significant difference was found at 24-month Rutherford levels. The incidence of severe claudication in group A was significantly higher than that in group B (13 [12.4%] for group A and 3 [2.8%] for group B, P = 0.035). The stenosis rate after predilatation in group B was significantly higher than that in group A (54.56 ± 5.36 for group A and 59.20 ± 6.21 for group B, P = 0.012). The distribution of full patency in the 12th month in group B was significantly higher than that in group A. The rate of 70-100% stenosis in the 12th month was significantly higher in group A than in group B. According to the groups, the distribution of the patients who were lost to follow-up and died during the follow-up and secondary results, primary patency rates, and 2-year disease-free survival rates were also similar.

CONCLUSIONS

Atherectomy combined with DCB is superior for the long-term treatment of LE-PAD.

摘要

背景

本研究的目的是比较单纯药物涂层球囊(DCB)血管成形术与定向斑块旋切术(DA)联合DCB血管成形术治疗下肢外周动脉疾病(LE-PAD)患者的效果。

方法

纳入单纯接受DCB血管成形术治疗的患者(A组)和接受DA联合DCB血管成形术治疗的患者(B组)。对4年间的病历进行回顾性分析。纳入患有严重闭塞性LE-PAD的患者。记录人口统计学数据、动脉粥样硬化血管特性和手术数据。呈现两组的成功率(技术成功率、手术成功率和临床成功率)。

结果

共评估了226例患者。就基线特征而言,仅B组的吸烟率和高脂血症发生率更高(分别为P = 0.001和P = 0.010)。在第1个月、第3个月、第6个月、第12个月或第24个月的随访中,踝肱指数无显著差异。根据分组,在第1个月、第3个月、第6个月或第12个月时,Rutherford分级无显著差异。在24个月时的Rutherford分级水平存在显著差异。A组严重跛行的发生率显著高于B组(A组为13例[12.4%],B组为3例[2.8%],P = 0.035)。B组预扩张后的狭窄率显著高于A组(A组为54.56±5.36,B组为59.20±6.21,P = 0.012)。B组在第12个月时完全通畅的分布显著高于A组。A组在第12个月时70%-100%狭窄的发生率显著高于B组。根据分组,随访期间失访和死亡患者的分布以及次要结果、原发性通畅率和2年无病生存率也相似。

结论

斑块旋切术联合DCB在LE-PAD的长期治疗中更具优势。

相似文献

1
Comparison of Drug-Coated Balloon Angioplasty Alone and Directional Atherectomy Combined with Drug-Coated Balloon Angioplasty in Patients with Lower Extremity Peripheral Arterial Disease with Claudication.单纯药物涂层球囊血管成形术与定向斑块旋切术联合药物涂层球囊血管成形术治疗下肢间歇性跛行外周动脉疾病患者的比较
Ann Vasc Surg. 2023 Mar;90:162-171. doi: 10.1016/j.avsg.2022.10.007. Epub 2022 Oct 28.
2
Efficacy and safety of adjunctive drug-coated balloon therapy in endovascular treatment of common femoral artery disease.药物涂层球囊辅助治疗股总动脉疾病的血管内治疗的疗效和安全性。
Cardiovasc Revasc Med. 2019 Mar;20(3):210-214. doi: 10.1016/j.carrev.2018.06.018. Epub 2018 Jun 25.
3
Midterm Outcome of Directional Atherectomy Combined with Drug-Coated Balloon Angioplasty Versus Drug-Coated Balloon Angioplasty Alone for Femoropopliteal Arteriosclerosis Obliterans.定向旋切术联合药物涂层球囊血管成形术与单纯药物涂层球囊血管成形术治疗股腘动脉硬化闭塞症的中期疗效
Ann Vasc Surg. 2020 Apr;64:181-187. doi: 10.1016/j.avsg.2019.06.014. Epub 2019 Aug 23.
4
Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Isolated Popliteal Artery Lesions.抗再狭窄治疗的定向斑块旋切术与单纯药物涂层球囊血管成形术治疗孤立性腘动脉病变的比较
J Endovasc Ther. 2017 Apr;24(2):181-188. doi: 10.1177/1526602816683933. Epub 2016 Dec 23.
5
Efficacy of Rotational Atherectomy Followed by Drug-coated Balloon Angioplasty for the Treatment of Femoropopliteal Lesions-Comparison with Sole Drug-coated Balloon Revascularization: Two-year Outcomes.药物涂层球囊血管成形术治疗股腘病变的疗效-与单纯药物涂层球囊血管再通术的比较:两年结果。
Ann Vasc Surg. 2021 May;73:222-233. doi: 10.1016/j.avsg.2020.10.051. Epub 2021 Jan 21.
6
Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Common Femoral Artery Atherosclerotic Disease.药物涂层球囊血管成形术与定向斑块切除术联合抗再狭窄治疗在股总动脉粥样硬化疾病中的应用。
J Endovasc Ther. 2018 Feb;25(1):92-99. doi: 10.1177/1526602817748319. Epub 2017 Dec 18.
7
Early outcomes of novel Temren atherectomy device combined with drug-coated balloon angioplasty for treatment of femoropopliteal lesions.新型 Temren 动脉旋切装置联合药物涂层球囊血管成形术治疗股腘动脉病变的早期结果。
Vascular. 2022 Aug;30(4):739-748. doi: 10.1177/17085381211029819. Epub 2021 Jun 28.
8
Comparison of paclitaxel-coated balloon angioplasty with femoropopliteal bypass surgery in treating femoropopliteal lesions.紫杉醇涂层球囊血管成形术与股腘动脉旁路移植术治疗股腘动脉病变的比较。
Vascular. 2021 Apr;29(2):260-269. doi: 10.1177/1708538120950116. Epub 2020 Aug 24.
9
Directional Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis and Maintain Vessel Patency: Twelve-Month Results of the DEFINITIVE AR Study.定向旋切术联合紫杉醇涂层球囊抑制再狭窄和维持管腔通畅:DEFINITIVE AR 研究的 12 个月结果。
Circ Cardiovasc Interv. 2017 Sep;10(9):e004848. doi: 10.1161/CIRCINTERVENTIONS.116.004848.
10
Mid-term outcomes of orbital atherectomy combined with drug-coated balloon angioplasty for treatment of femoropopliteal disease.轨道斑块旋切术联合药物涂层球囊血管成形术治疗股腘动脉疾病的中期结果
Catheter Cardiovasc Interv. 2017 May;89(6):1078-1085. doi: 10.1002/ccd.26984. Epub 2017 Mar 15.

引用本文的文献

1
The efficacy and safety of atherectomy combined with drug-coated balloon angioplasty vs. drug-coated balloon angioplasty for the treatment of lower extremity artery disease: a systematic review and meta-analysis.斑块旋切术联合药物涂层球囊血管成形术与药物涂层球囊血管成形术治疗下肢动脉疾病的疗效和安全性:一项系统评价和荟萃分析。
Front Cardiovasc Med. 2024 Sep 27;11:1472064. doi: 10.3389/fcvm.2024.1472064. eCollection 2024.
2
The Midterm Outcomes of Endovascular Therapy for Femoropopliteal Lesions via Drug-Coated Balloon, Directional Atherectomy and Bare Metal Stent Angioplasty.经药物涂层球囊、定向斑块旋切术和裸金属支架血管成形术治疗股腘动脉病变的血管内治疗中期结果
Rev Cardiovasc Med. 2024 Sep 18;25(9):331. doi: 10.31083/j.rcm2509331. eCollection 2024 Sep.
3
2024 TSOC/TSPS Joint Consensus: Strategies for Advanced Vascular Wound Management in Arterial and Venous Diseases.2024年TSOC/TSPS联合共识:动静脉疾病中晚期血管伤口管理策略
Acta Cardiol Sin. 2024 Jan;40(1):1-44. doi: 10.6515/ACS.202401_40(1).20231220A.
4
Comparison of mid-outcome among bare metal stent, atherectomy with or without drug-coated balloon angioplasty for femoropopliteal arterial occlusion.股浅动脉闭塞行药物涂层球囊血管成形术与或不与旋切术治疗的金属裸支架的中期结果比较。
Sci Rep. 2024 Jan 2;14(1):63. doi: 10.1038/s41598-023-50511-8.